IP Library › Granted Patent US 11,890,442
Granted Patent B2
US 11,890,442 · App. 16/961,213 · Granted Feb 6, 2024

Systems and methods for locating and identifying an implanted medical device

Inventor: Murtaza Y. Amin (Farmington, UT)
Assignee: Bard Peripheral Vascular, Inc.
A61M39/0208A61M5/14276A61M2039/0238A61M2205/502A61M2205/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,890,442
App. No.
16/961,213
Granted
Feb 6, 2024
Kind
B2
Abstract

Systems and methods for detecting an implanted medical device, such as a vascular access port. The implanted medical device may include at least one passive RFID tag that has disposed thereon information about the implanted medical device. The at least one passive RFID tag is designed to be interrogated by a detector associated with an external device, such as an infusion set with an access needle. The interrogating signal induces a return signal from the at least one passive RFID tags. The strength of the return signal may be dependent on the distance and orientation of the tag relative to the detector. The system may be designed to interpret different signal strengths from different RFID tags to guide the needle to a correct insertion position, thereby accessing a port that cannot be readily detected visually or by palpation.

Claims (22)

1. A subcutaneous detection system, comprising:

a vascular access port system, comprising:

a body enclosing a fluid reservoir, an outlet of the body in communication with the fluid reservoir;

a needle-penetrable septum covering the fluid reservoir;

a catheter having a proximal end coupled to the outlet and a distal end including an opening; and

a RFID tag system, including at least a first RFID tag and a second RFID tag coupled to the body, the first RFID tag and the second RFID tag in a co-planar arrangement; and

an infusion set, comprising:

a detector providing an interrogation signal inducing the RFID tag system to provide a return signal; and

a needle extending through a central hole in the detector.

2. The subcutaneous detection system according to claim 1 , wherein the detector uses a strength of the return signal to determine a location of the RFID tag system relative to the detector.

3. The subcutaneous detection system according to claim 1 , wherein the detector uses a strength of the return signal to determine an orientation of the RFID tag system relative to the detector.

4. The subcutaneous detection system according to claim 1 , wherein the RFID tag system includes information encoded thereon pertaining to the vascular access port system.

5. The subcutaneous detection system according to claim 4 , wherein the information encoded on the RFID tag system is selected from the group consisting of make of the vascular access port system, model of the vascular access port system, vascular access port system composition, vascular access port system capabilities, date of manufacture, serial number, lot number, and combinations thereof.

6. The subcutaneous detection system according to claim 1 , further comprising a user interface device for interpreting and displaying information encoded in the return signal from the RFID tag system.

7. The subcutaneous detection system according to claim 6 , wherein the user interface device includes a display for depicting written, numerical, or iconic information about the vascular access port system.

8. The subcutaneous detection system according to claim 6 , wherein the user interface device includes a display for depicting written, numerical, or iconic information about a location and orientation of the vascular access port system.

9. The subcutaneous detection system according to claim 6 , wherein the user interface device includes one of a laptop, computer terminal, mobile device, palm top, smartphone, tablet, wearable device, smartwatch, heads up display (HUD), Virtual Reality (VR) device, and Augmented Reality (AR) device.

10. The subcutaneous detection system according to claim 1 , wherein the first RFID tag is positioned at a first port location of the vascular access port system, and wherein the second RFID tag is positioned at a second port location of the vascular access port system opposite of the first port location.

11. The subcutaneous detection system according to claim 1 , wherein the RFID tag system further comprises a third RFID tag co-planar with the first RFID tag and the second RFID tag, and wherein the first RFID tag is spaced equidistant from the second RFID tag and the third RFID tag.

12. The subcutaneous detection system according to claim 11 , wherein the first RFID tag, the second RFID tag, and the third RFID tag are spaced equidistant from a centerpoint of the needle-penetrable septum.

13. The subcutaneous detection system according to claim 1 , wherein the RFID tag system further comprises a third RFID tag and a fourth RFID tag, both co-planar with the first RFID tag and the second RFID tag, and wherein the first RFID tag, the second RFID tag, the third RFID tag, and the fourth RFID tag are spaced equidistant about the vascular access port system.

14. The subcutaneous detection system according to claim 13 , wherein the first RFID tag, the second RFID tag, the third RFID tag, and the fourth RFID tag are spaced equidistant from a centerpoint of the needle-penetrable septum.

Continuity (2)
Provisional Application 62622555 · Jan 26, 2018
Related Publication 20200368513A1 · Nov 26, 2020